Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Truvada
Pharma
Gilead moves ahead with $247M settlement in HIV antitrust case
The preliminary settlement deal comes after Gilead and Teva, a generics giant, prevailed in a high-stakes jury trial this summer.
Eric Sagonowsky
Sep 26, 2023 10:39am
Gilead, Teva cleared of HIV pay-for-delay claims after trial
Jul 5, 2023 12:07pm
US appeal in Gilead patent case gets patient advocates' support
May 31, 2023 4:20pm
Gilead bests US government in HIV PrEP patent case
May 9, 2023 4:45pm
Gilead, US set to clash at trial over PrEP drug patents
May 2, 2023 9:35am
European AIDS advocacy group keeps Gilead in the crosshairs
Mar 14, 2023 12:29pm